Revenue Agenda
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
No Result
View All Result
Revenue Agenda
No Result
View All Result
Home Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

admin by admin
December 20, 2024
in Investing
0
RAD 202 receives approval to start Phase 1 therapeutic trial
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

Previous Post

Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation

 Next Post

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis
Next Post
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

  • Trending
  • Comments
  • Latest
Sen. Peter Welch says Israel ground invasion would ‘exacerbate’ conditions in Gaza: ‘Grave concerns’

Sen. Peter Welch says Israel ground invasion would ‘exacerbate’ conditions in Gaza: ‘Grave concerns’

October 24, 2023
Walmart Stock Hits Record High on Earnings Beat

Walmart Stock Hits Record High on Earnings Beat

August 17, 2024
Gold and silver: gold enters a certain consolidation zone

Gold and silver: gold enters a certain consolidation zone

August 16, 2024
EURUSD and GBPUSD: EURUSD exceeds last week’s high

EURUSD and GBPUSD: EURUSD exceeds last week’s high

August 19, 2024
FALCO ANNOUNCES CLOSING OF BROKERED PRIVATE PLACEMENT

FALCO ANNOUNCES CLOSING OF BROKERED PRIVATE PLACEMENT

0
New Hampshire Gov. Sununu signs $15.2B ‘miracle’ budget into law

New Hampshire Gov. Sununu signs $15.2B ‘miracle’ budget into law

0

Pennsylvania House clears tax credits for new teachers, nurses, police officers

0
Evers signs bipartisan sales tax bill aimed at sparing Milwaukee from bankruptcy

Evers signs bipartisan sales tax bill aimed at sparing Milwaukee from bankruptcy

0
FALCO ANNOUNCES CLOSING OF BROKERED PRIVATE PLACEMENT

FALCO ANNOUNCES CLOSING OF BROKERED PRIVATE PLACEMENT

December 21, 2024
Silver Price Forecast: Top Trends That Will Affect Silver in 2025

Silver Price Forecast: Top Trends That Will Affect Silver in 2025

December 21, 2024
Opawica Announces the Closing of Non-Brokered Private Placement

Opawica Announces the Closing of Non-Brokered Private Placement

December 21, 2024
Top 5 Canadian Mining Stocks This Week: Omineca Jumps 67 Percent

Top 5 Canadian Mining Stocks This Week: Omineca Jumps 67 Percent

December 21, 2024
Enter Your Information Below To Receive Trading Ideas and Latest News

Error: Contact form not found.

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent News

FALCO ANNOUNCES CLOSING OF BROKERED PRIVATE PLACEMENT

FALCO ANNOUNCES CLOSING OF BROKERED PRIVATE PLACEMENT

December 21, 2024
Silver Price Forecast: Top Trends That Will Affect Silver in 2025

Silver Price Forecast: Top Trends That Will Affect Silver in 2025

December 21, 2024
Opawica Announces the Closing of Non-Brokered Private Placement

Opawica Announces the Closing of Non-Brokered Private Placement

December 21, 2024
Top 5 Canadian Mining Stocks This Week: Omineca Jumps 67 Percent

Top 5 Canadian Mining Stocks This Week: Omineca Jumps 67 Percent

December 21, 2024
  • About us
  • Privacy Policy
  • Terms & Conditions
  • About us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2024 Revenueagenda.com All Rights Reserved.

No Result
View All Result
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy

Copyright © 2024 Revenueagenda.com All Rights Reserved.